Stay updated on EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Sign up to get notified when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T20:15:24.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    - Revision: v3.4.2 added and Revision: v3.4.1 removed. This is a site maintenance update and does not modify study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T21:08:16.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Administrative notices about government funding and site status were added, along with revision metadata (Revision: v3.4.1 and dates like 2026-02-02 and 2027-02-26). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T11:01:14.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Show glossary has been added, and timestamp/metadata labels have been updated to include 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', along with a new 'Revision: v3.4.0' line. The older labels such as 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', and 'No FEAR Act data' appear to be adjusted or removed, reflecting UI/metadata changes rather than core content.
    Difference
    0.2%
    Check dated 2026-01-28T06:38:41.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous v3.3.3. This is a metadata update and does not modify the study details or outcomes.
    Difference
    0.0%
    Check dated 2026-01-14T02:56:06.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Adds a consolidated Locations section listing Arkansas, California, Jilin, Hauts De Seine, FI, and Barcelona, and updates the page revision to v3.3.3. Removes the separate Arkansas Locations, California Locations, Jilin Locations, Hauts De Seine Locations, FI Locations, and Barcelona Locations entries.
    Difference
    0.7%
    Check dated 2025-12-23T17:29:11.000Z thumbnail image

Stay in the know with updates to EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.